Literature DB >> 9867102

Prognostic value of progressive decrease in serum cholesterol in predicting survival in Child-Pugh C viral cirrhosis.

A D'Arienzo1, F Manguso, G Scaglione, G Vicinanza, R Bennato, G Mazzacca.   

Abstract

BACKGROUND: The identification of cirrhotic patients with low life expectancy is an open clinical problem. Hypocholesterolemia is frequently found in severe chronic hepatic insufficiency because the liver is the most active site of cholesterol metabolism, but poor information is available on its precise prognostic value. We evaluated the prognostic role of hypocholesterolemia in patients with advanced liver cirrhosis.
METHODS: Serial serum cholesterol concentrations of 34 patients with virus-induced cirrhosis, from the first appearance of Child-Pugh class C to death, were considered. To compare survival functions, we established three base-line cholesterol cut-off points (150, 125, and 100 mg/dl) and stratified patients into groups A and B, with base-line cholesterol levels lower and higher than each cut-off value, respectively.
RESULTS: Cholesterolemia decreased progressively in all patients. At the 100 mg/dl cut-off point all group-A patients died within 17 months, whereas 75% of group-B patients were alive at 24 months (P < 0.0001). Moreover, cholesterolemia was significantly correlated with cholinesterase, indirect bilirubin, and total bilirubin at entry time and immediately before death. No correlation was observed between cholesterol and these variables when stratified for the Child-Pugh score.
CONCLUSIONS: Base-line serum cholesterol levels lower than 100 mg/dl identify a subgroup of Child-C cirrhotic patients with high mortality risk within a 2-year follow-up. The prognostic importance of cholesterolemia may also be deduced by the significant correlation with other well-established indicators of survival.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9867102     DOI: 10.1080/00365529850172593

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  11 in total

Review 1.  Abnormalities of Lipoprotein Levels in Liver Cirrhosis: Clinical Relevance.

Authors:  Graziella Privitera; Luisa Spadaro; Simona Marchisello; Giuseppe Fede; Francesco Purrello
Journal:  Dig Dis Sci       Date:  2017-11-25       Impact factor: 3.199

2.  Is nonalcoholic steatohepatitis associated with a high-though-normal thyroid stimulating hormone level and lower cholesterol levels?

Authors:  Lucia Carulli; Stefano Ballestri; Amedeo Lonardo; Francesca Lami; Enrico Violi; Luisa Losi; Lisa Bonilauri; Anna Maria Verrone; Maria Rosaria Odoardi; Federica Scaglioni; Marco Bertolotti; Paola Loria
Journal:  Intern Emerg Med       Date:  2011-05-11       Impact factor: 3.397

3.  Liver disease alters high-density lipoprotein composition, metabolism and function.

Authors:  Markus Trieb; Angela Horvath; Ruth Birner-Gruenberger; Walter Spindelboeck; Vanessa Stadlbauer; Ulrike Taschler; Sanja Curcic; Rudolf E Stauber; Michael Holzer; Lisa Pasterk; Akos Heinemann; Gunther Marsche
Journal:  Biochim Biophys Acta       Date:  2016-04-19

4.  Hepatitis C infection is associated with lower lipids and high-sensitivity C-reactive protein in HIV-infected men.

Authors:  Michelle Floris-Moore; Andrea A Howard; Yungtai Lo; Ellie E Schoenbaum; Julia H Arnsten; Robert S Klein
Journal:  AIDS Patient Care STDS       Date:  2007-07       Impact factor: 5.078

5.  Coronary artery disease in patients with liver cirrhosis.

Authors:  Evangelos Kalaitzakis; Annika Rosengren; Tomas Skommevik; Einar Björnsson
Journal:  Dig Dis Sci       Date:  2009-02-26       Impact factor: 3.199

6.  Is cholesterol a conditionally essential nutrient in critically ill patients?

Authors:  Wilfred Druml
Journal:  Wien Klin Wochenschr       Date:  2003-11-28       Impact factor: 2.275

7.  Hypolipidemia: a word of caution.

Authors:  Rr Elmehdawi
Journal:  Libyan J Med       Date:  2008-06-01       Impact factor: 1.657

8.  Favorable clinical outcome of nonalcoholic liver cirrhosis patients with coronary artery disease: A population-based study.

Authors:  Ming-Chang Tsai; Tzu-Wei Yang; Chi-Chih Wang; Yao-Tung Wang; Wen-Wei Sung; Ming-Hseng Tseng; Chun-Che Lin
Journal:  World J Gastroenterol       Date:  2018-08-21       Impact factor: 5.742

Review 9.  Hypothalamus-Pituitary-Adrenal Dysfunction in Cholestatic Liver Disease.

Authors:  Anca D Petrescu; Jessica Kain; Victoria Liere; Trace Heavener; Sharon DeMorrow
Journal:  Front Endocrinol (Lausanne)       Date:  2018-11-12       Impact factor: 5.555

10.  Association of Low High-Density Lipoprotein Cholesterol Levels with Poor Outcomes in Hepatitis B-Associated Decompensated Cirrhosis Patients.

Authors:  Xia He; XiaoYun Liu; SongQing Peng; Zhong Han; Jianjiang Shen; Ming Cai
Journal:  Biomed Res Int       Date:  2021-07-27       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.